1580 16. D. Fischer, H. Dautzenberg, K. Kunath, and T. Kissel. Poly (diallyldimethylammonium chlorides) and their N-methyl-N- vinylacetamide copolymer-based DNA-polyplexes: role of mo- lecular weight and charge density in complex formation, stability, and in vitro activity. Int. J. Pharm. 280:253–269 (2004). 17. D. G. Anderson, A. Akinc, N. Hossain, and R. Langer. Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol. Ther. 11:426–434 (2005). 18. M. Breunig, U. Lungwitz, R. Liebl, C. Fontanari, J. Klar, A. Kurtz, T. Blunk, and A. Goepferich. Gene delivery with low molecular weight linear polyethylenimines. J. Gene Med. 7:1287–1298 (2005). 19. P. Van De Wetering, J. Y. Cherng, H. Talsma, and W. E. Hennink. Relation between transfection efficiency and cytotox- icity of poly(2-(dimethylamino)ethyl methacrylate)/plasmid complexes. J. Control. Release 49:59–69 (1997). 20. M. Koping-Hoggard, K. M. Varum, M. Issa, S. Danielsen, B. E. Christensen, B. T. Stokke, and P. Artursson. Improved chitosan- mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 11:1441–1452 (2004). 21. D. V. Schaffer, N. A. Fidelman, N. Dan, and D. A. Lauffenburger. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 67:598–606 (2000). 22. J. Luten, J. H. Van Steenis, R. Van Someren, J. Kemmink, N. M. Schuurmans-Nieuwenbroek, G. A. Koning, D. J. A. Crommelin, C. F. Van Nostrum, and W. E. Hennink. Water-soluble biode- gradable cationic polyphosphazenes for gene delivery. J. Control. Release 89:483–497 (2003). 23. H. R. Allcock, M. B. Mcintosh, E. H. Klingenberg, and M. E. Napierala. Functionalized polyphosphazenes: Polymers with pendent tertiary trialkylamino groups. Macromolecules 31:5255–5263 (1998). 24. A. N. Mujumdar, S. G. Young, R. L. Merker, and J. H. Magill. A Study of Solution Polymerization of Polyphosphazenes. Macromolecules 23:14–21 (1990). 25. X. Jiang, A. Van Der Horst, M. J. Van Steenbergen, N. Akeroyd, C. F. Van Nostrum, P. J. Schoenmakers, and W. E. Hennink. Molar-mass characterization of cationic polymers for gene delivery by aqueous size-exclusion chromatography. Pharm. Res. 23:595–603 (2006). 26. P. Van De Wetering, J. Y. Cherng, H. Talsma, D. J. A. Crommelin, and W. E. Hennink. 2-(Dimethylamino)ethyl meth- acrylate based (co)polymers as gene transfer agents. J. Control. Release 53:145–153 (1998). de Wolf et al. 27. M. Kursa, G. F. Walker, V. Roessler, M. Ogris, W. Roedl, R. Kircheis, and E. Wagner. Novel shielded transferrin-polyeth- ylene glycol-polyethylenimine/DNA complexes for systemic tu- mor-targeted gene transfer. Bioconjug. Chem. 14:222–231 (2003). 28. M. X. Tang and F. C. Szoka. The influence of polymer structure on the interactions of cationic polymers with DNA and mor- phology of the resulting complexes. Gene Ther. 4:823–832 (1997). 29. D. A. Scudiero, R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827–4833 (1988). 30. F. Verbaan, I. Van Dam, Y. Takakura, M. Hashida, W. Hennink, G. Storm, and C. Oussoren. Intravenous fate of poly(2-(dimeth- ylamino)ethyl methacrylate)-based polyplexes. Eur. J. Pharm. Sci. 20:419–427 (2003). 31. M. Neu, D. Fischer, and T. Kissel. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J. Gene Med. 7:992–1009 (2005). 32. I. R. Hill, M. C. Garnett, F. Bignotti, and S. S. Davis. In vitro cytotoxicity of poly(amidoamine)s: relevance to DNA delivery. Biochim. Biophys. Acta 1427:161–174 (1999). 33. S. M. Moghimi, P. Symonds, J. C. Murray, A. C. Hunter, G. Debska, and A. Szewczyk. A two-stage poly(ethylenimine)- mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 11:990–995 (2005). 34. D. Fischer, T. Bieber, Y. Li, H. P. Elsasser, and T. Kissel. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfec- tion efficiency and cytotoxicity. Pharm. Res. 16:1273–1279 (1999). 35. L. Wightman, R. Kircheis, V. Rossler, S. Carotta, R. Ruzicka, M. Kursa, and E. Wagner. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3:362–372 (2001). 36. E. Moreau, M. Domurado, P. Chapon, M. Vert, and D. Domurad. Biocompatibility of polycations: in vitro aggluti- nation and lysis of red blood cells and in vivo toxicity. J. Drug Target. 10:161–173 (2002). 37. S. Boeckle, K. Von Gersdorff, S. Van Der Piepen, C. Culmsee, E. Wagner, and M. Ogris. Purification of polyethylenimine poly- plexes highlights the role of free polycations in gene transfer. J. Gene Med. 6:1102–1111 (2004). 38. R. Kircheis, L. Wightman, A. Schreiber, B. Robitza, V. Rossler, M. Kursa, and E. Wagner. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8:28–40 (2001).